Population pharmacokinetics of opicinumab (Anti-LINGO-1) guides the phase IIb dose selection

Chu, LH; Xu, L; Yin, W; Nestorov, I

MULTIPLE SCLEROSIS JOURNAL, 2017; 23 ( ): 620

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索